nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000565	0.000565	CcSEcCtD
Felbamate—Headache—Mometasone—systemic scleroderma	0.000565	0.000565	CcSEcCtD
Felbamate—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Felbamate—Insomnia—Mycophenolic acid—systemic scleroderma	0.000563	0.000563	CcSEcCtD
Felbamate—Fatigue—Leflunomide—systemic scleroderma	0.000563	0.000563	CcSEcCtD
Felbamate—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Felbamate—Oedema—Lisinopril—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Felbamate—Pruritus—Captopril—systemic scleroderma	0.00056	0.00056	CcSEcCtD
Felbamate—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Felbamate—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Felbamate—Constipation—Leflunomide—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Felbamate—Pain—Leflunomide—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Felbamate—Infection—Lisinopril—systemic scleroderma	0.000557	0.000557	CcSEcCtD
Felbamate—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000557	0.000557	CcSEcCtD
Felbamate—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000555	0.000555	CcSEcCtD
Felbamate—Somnolence—Mycophenolic acid—systemic scleroderma	0.000554	0.000554	CcSEcCtD
Felbamate—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000553	0.000553	CcSEcCtD
Felbamate—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Felbamate—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000548	0.000548	CcSEcCtD
Felbamate—Tachycardia—Lisinopril—systemic scleroderma	0.000547	0.000547	CcSEcCtD
Felbamate—Abdominal pain—Azathioprine—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Felbamate—Body temperature increased—Azathioprine—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Felbamate—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000543	0.000543	CcSEcCtD
Felbamate—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Felbamate—Diarrhoea—Captopril—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Felbamate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Felbamate—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000539	0.000539	CcSEcCtD
Felbamate—Feeling abnormal—Leflunomide—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Felbamate—Fatigue—Mycophenolic acid—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Felbamate—Mood swings—Methotrexate—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Felbamate—Nausea—Mometasone—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Felbamate—Anorexia—Lisinopril—systemic scleroderma	0.000535	0.000535	CcSEcCtD
Felbamate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Felbamate—Weight increased—Prednisone—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Felbamate—Ataxia—Methotrexate—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Felbamate—Pain—Mycophenolic acid—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Felbamate—Constipation—Mycophenolic acid—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Felbamate—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000532	0.000532	CcSEcCtD
Felbamate—Weight decreased—Prednisone—systemic scleroderma	0.00053	0.00053	CcSEcCtD
Felbamate—Hyperglycaemia—Prednisone—systemic scleroderma	0.000528	0.000528	CcSEcCtD
Felbamate—Cough—Mycophenolate mofetil—systemic scleroderma	0.000526	0.000526	CcSEcCtD
Felbamate—Hypotension—Lisinopril—systemic scleroderma	0.000524	0.000524	CcSEcCtD
Felbamate—Dizziness—Captopril—systemic scleroderma	0.000524	0.000524	CcSEcCtD
Felbamate—Depression—Prednisone—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Felbamate—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00052	0.00052	CcSEcCtD
Felbamate—Urticaria—Leflunomide—systemic scleroderma	0.000519	0.000519	CcSEcCtD
Felbamate—Abdominal pain—Leflunomide—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Felbamate—Body temperature increased—Leflunomide—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Felbamate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Felbamate—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Felbamate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Felbamate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000511	0.000511	CcSEcCtD
Felbamate—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000511	0.000511	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Felbamate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Felbamate—Insomnia—Lisinopril—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Felbamate—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Felbamate—Paraesthesia—Lisinopril—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Felbamate—Vomiting—Captopril—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Felbamate—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000501	0.000501	CcSEcCtD
Felbamate—Dyspnoea—Lisinopril—systemic scleroderma	0.0005	0.0005	CcSEcCtD
Felbamate—Rash—Captopril—systemic scleroderma	0.000499	0.000499	CcSEcCtD
Felbamate—Dermatitis—Captopril—systemic scleroderma	0.000499	0.000499	CcSEcCtD
Felbamate—Somnolence—Lisinopril—systemic scleroderma	0.000499	0.000499	CcSEcCtD
Felbamate—Headache—Captopril—systemic scleroderma	0.000496	0.000496	CcSEcCtD
Felbamate—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000496	0.000496	CcSEcCtD
Felbamate—Dyspepsia—Lisinopril—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Felbamate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Felbamate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Felbamate—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Felbamate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Felbamate—Asthma—Methotrexate—systemic scleroderma	0.00049	0.00049	CcSEcCtD
Felbamate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Felbamate—Decreased appetite—Lisinopril—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Felbamate—Eosinophilia—Methotrexate—systemic scleroderma	0.000485	0.000485	CcSEcCtD
Felbamate—Fatigue—Lisinopril—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Felbamate—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Felbamate—Pancreatitis—Methotrexate—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Felbamate—Pain—Lisinopril—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Felbamate—Constipation—Lisinopril—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Felbamate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Felbamate—Bradycardia—Prednisone—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Felbamate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Felbamate—Diarrhoea—Azathioprine—systemic scleroderma	0.000473	0.000473	CcSEcCtD
Felbamate—Haemoglobin—Prednisone—systemic scleroderma	0.000471	0.000471	CcSEcCtD
Felbamate—Nausea—Captopril—systemic scleroderma	0.000471	0.000471	CcSEcCtD
Felbamate—Haemorrhage—Prednisone—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Felbamate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Felbamate—Asthenia—Leflunomide—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Felbamate—Hallucination—Prednisone—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Felbamate—Pancytopenia—Methotrexate—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Felbamate—Feeling abnormal—Lisinopril—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Felbamate—Pruritus—Leflunomide—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Felbamate—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Felbamate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Felbamate—Dysuria—Methotrexate—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Felbamate—Dizziness—Azathioprine—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Felbamate—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Felbamate—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Felbamate—Asthenia—Mycophenolic acid—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Felbamate—Diarrhoea—Leflunomide—systemic scleroderma	0.000447	0.000447	CcSEcCtD
Felbamate—Urticaria—Lisinopril—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Felbamate—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000445	0.000445	CcSEcCtD
Felbamate—Body temperature increased—Lisinopril—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Felbamate—Abdominal pain—Lisinopril—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Felbamate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Felbamate—Pruritus—Mycophenolic acid—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Felbamate—Vomiting—Azathioprine—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Felbamate—Pneumonia—Methotrexate—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Felbamate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000438	0.000438	CcSEcCtD
Felbamate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Felbamate—Rash—Azathioprine—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Felbamate—Dermatitis—Azathioprine—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Felbamate—Depression—Methotrexate—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Felbamate—Flushing—Prednisone—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Felbamate—Headache—Azathioprine—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Felbamate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Felbamate—Dizziness—Leflunomide—systemic scleroderma	0.000432	0.000432	CcSEcCtD
Felbamate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000427	0.000427	CcSEcCtD
Felbamate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Felbamate—Conjunctivitis—Methotrexate—systemic scleroderma	0.000424	0.000424	CcSEcCtD
Felbamate—Pain—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Felbamate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Felbamate—Sweating—Methotrexate—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Felbamate—Haematuria—Methotrexate—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Felbamate—Vomiting—Leflunomide—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Felbamate—Alopecia—Prednisone—systemic scleroderma	0.000414	0.000414	CcSEcCtD
Felbamate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Felbamate—Epistaxis—Methotrexate—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Felbamate—Rash—Leflunomide—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Felbamate—Dermatitis—Leflunomide—systemic scleroderma	0.000411	0.000411	CcSEcCtD
Felbamate—Nausea—Azathioprine—systemic scleroderma	0.000411	0.000411	CcSEcCtD
Felbamate—Headache—Leflunomide—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Felbamate—Agranulocytosis—Methotrexate—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Felbamate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Felbamate—Asthenia—Lisinopril—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Felbamate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Felbamate—Pruritus—Lisinopril—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Felbamate—Vomiting—Mycophenolic acid—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Felbamate—Haemoglobin—Methotrexate—systemic scleroderma	0.000394	0.000394	CcSEcCtD
Felbamate—Rash—Mycophenolic acid—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Felbamate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Felbamate—Haemorrhage—Methotrexate—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Felbamate—Hepatitis—Methotrexate—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Felbamate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00039	0.00039	CcSEcCtD
Felbamate—Headache—Mycophenolic acid—systemic scleroderma	0.00039	0.00039	CcSEcCtD
Felbamate—Pharyngitis—Methotrexate—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Felbamate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Felbamate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Felbamate—Nausea—Leflunomide—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Felbamate—Diarrhoea—Lisinopril—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Felbamate—Ill-defined disorder—Prednisone—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Felbamate—Visual impairment—Methotrexate—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Felbamate—Anaemia—Prednisone—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Felbamate—Agitation—Prednisone—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Felbamate—Dizziness—Lisinopril—systemic scleroderma	0.000371	0.000371	CcSEcCtD
Felbamate—Erythema multiforme—Methotrexate—systemic scleroderma	0.000371	0.000371	CcSEcCtD
Felbamate—Nausea—Mycophenolic acid—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Felbamate—Malaise—Prednisone—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Felbamate—Vomiting—Lisinopril—systemic scleroderma	0.000357	0.000357	CcSEcCtD
Felbamate—Rash—Lisinopril—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Felbamate—Dermatitis—Lisinopril—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Felbamate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Felbamate—Hypertension—Prednisone—systemic scleroderma	0.000352	0.000352	CcSEcCtD
Felbamate—Chills—Methotrexate—systemic scleroderma	0.000352	0.000352	CcSEcCtD
Felbamate—Headache—Lisinopril—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Felbamate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Felbamate—Arthralgia—Prednisone—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Felbamate—Myalgia—Prednisone—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Felbamate—Anxiety—Prednisone—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Felbamate—Alopecia—Methotrexate—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Felbamate—Discomfort—Prednisone—systemic scleroderma	0.000343	0.000343	CcSEcCtD
Felbamate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Felbamate—Dysgeusia—Methotrexate—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Felbamate—Nausea—Lisinopril—systemic scleroderma	0.000333	0.000333	CcSEcCtD
Felbamate—Anaphylactic shock—Prednisone—systemic scleroderma	0.000333	0.000333	CcSEcCtD
Felbamate—Oedema—Prednisone—systemic scleroderma	0.000333	0.000333	CcSEcCtD
Felbamate—Infection—Prednisone—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Felbamate—Tachycardia—Prednisone—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Felbamate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Felbamate—Hyperhidrosis—Prednisone—systemic scleroderma	0.000322	0.000322	CcSEcCtD
Felbamate—Anorexia—Prednisone—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Felbamate—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000317	0.000317	CcSEcCtD
Felbamate—Anaemia—Methotrexate—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Felbamate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Felbamate—Rash—Mycophenolate mofetil—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Felbamate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Felbamate—Headache—Mycophenolate mofetil—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Felbamate—Malaise—Methotrexate—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Felbamate—Leukopenia—Methotrexate—systemic scleroderma	0.000305	0.000305	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Felbamate—Insomnia—Prednisone—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Felbamate—Paraesthesia—Prednisone—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Felbamate—Cough—Methotrexate—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Felbamate—Dyspepsia—Prednisone—systemic scleroderma	0.000293	0.000293	CcSEcCtD
Felbamate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Felbamate—Arthralgia—Methotrexate—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Felbamate—Myalgia—Methotrexate—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Felbamate—Chest pain—Methotrexate—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Felbamate—Decreased appetite—Prednisone—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Felbamate—Fatigue—Prednisone—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Felbamate—Discomfort—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Felbamate—Constipation—Prednisone—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Felbamate—Confusional state—Methotrexate—systemic scleroderma	0.000281	0.000281	CcSEcCtD
Felbamate—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Felbamate—Infection—Methotrexate—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Felbamate—Feeling abnormal—Prednisone—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Felbamate—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Felbamate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Felbamate—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000269	0.000269	CcSEcCtD
Felbamate—Anorexia—Methotrexate—systemic scleroderma	0.000265	0.000265	CcSEcCtD
Felbamate—Urticaria—Prednisone—systemic scleroderma	0.000265	0.000265	CcSEcCtD
Felbamate—Body temperature increased—Prednisone—systemic scleroderma	0.000263	0.000263	CcSEcCtD
Felbamate—Abdominal pain—Prednisone—systemic scleroderma	0.000263	0.000263	CcSEcCtD
Felbamate—Hypotension—Methotrexate—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000254	0.000254	CcSEcCtD
Felbamate—Insomnia—Methotrexate—systemic scleroderma	0.000252	0.000252	CcSEcCtD
Felbamate—Paraesthesia—Methotrexate—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Felbamate—Dyspnoea—Methotrexate—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Felbamate—Somnolence—Methotrexate—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Felbamate—Dyspepsia—Methotrexate—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Felbamate—Decreased appetite—Methotrexate—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Felbamate—Fatigue—Methotrexate—systemic scleroderma	0.00024	0.00024	CcSEcCtD
Felbamate—Asthenia—Prednisone—systemic scleroderma	0.000239	0.000239	CcSEcCtD
Felbamate—Pain—Methotrexate—systemic scleroderma	0.000238	0.000238	CcSEcCtD
Felbamate—Pruritus—Prednisone—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Felbamate—Feeling abnormal—Methotrexate—systemic scleroderma	0.000229	0.000229	CcSEcCtD
Felbamate—Diarrhoea—Prednisone—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Felbamate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Felbamate—Urticaria—Methotrexate—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Felbamate—Dizziness—Prednisone—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Felbamate—Abdominal pain—Methotrexate—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Felbamate—Body temperature increased—Methotrexate—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Felbamate—Vomiting—Prednisone—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Felbamate—Rash—Prednisone—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Felbamate—Dermatitis—Prednisone—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Felbamate—Headache—Prednisone—systemic scleroderma	0.000209	0.000209	CcSEcCtD
Felbamate—Asthenia—Methotrexate—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Felbamate—Nausea—Prednisone—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Felbamate—Pruritus—Methotrexate—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Felbamate—Diarrhoea—Methotrexate—systemic scleroderma	0.000191	0.000191	CcSEcCtD
Felbamate—Dizziness—Methotrexate—systemic scleroderma	0.000184	0.000184	CcSEcCtD
Felbamate—Vomiting—Methotrexate—systemic scleroderma	0.000177	0.000177	CcSEcCtD
Felbamate—Rash—Methotrexate—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Felbamate—Dermatitis—Methotrexate—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Felbamate—Headache—Methotrexate—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Felbamate—Nausea—Methotrexate—systemic scleroderma	0.000165	0.000165	CcSEcCtD
